MorphoSys AG has announced the successful completion of a new proprietary antibody library, HuCAL PLATINUM. Initial results show that the new antibody library, which is approximately three-times larger than the former version, HuCAL GOLD, can provide a more diverse range of fully human antibodies. In addition, the new technology enables the generation of antibodies having higher affinity as well as improved expression rates. The improvements achieved with this next generation antibody library are expected to significantly shorten timelines from antibody discovery to pre-clinical development and result in antibody drug candidates with improved characteristics.

MorphoSys AG and Sigma Aldrich Corp. plan to cooperate on the design, production and distribution of research antibodies using MorphoSys’ technology. MorphoSys’ AbD Serotec unit plans to develop antibodies against a specific number of targets supplied by Sigma Aldrich, and Sigma Aldrich will offer the antibodies for use in research applications through its online sales platforms.

Full story here.